Sponsor: GOG Foundation
Sponsor Study ID: GOG-3068
Study Title: 3068/217908 A Phase III Randomized Trial of Heated Intraperitoneal Chemotherapy (HIPEC) with Cisplatin versus no HIPEC at the Time of Optimal Interval Cytoreductive Surgery followed by Niraparib Maintenance in Patients with Newly Diagnosed Stage III and IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
CTO #: 103913
NCT Number: NCT05659381
Phase: III
Protocol Type: Treatment
Age Group: Adults
Disease Sites: Other Female Genital, Ovary
Study Objectives: To determine if a single treatment with intraoperative HIPEC with cisplatin at the time of iCRS will result in improved PFS as compared to iCRS alone in patients with stage III or IV EOC who are treated with neoadjuvant IV platinum-based chemotherapy followed by niraparib maintenance.